Skip to main content
. 2021 Aug 17;8:663670. doi: 10.3389/fmed.2021.663670

Table 7.

Primary (on admission) hematological findings and the post-COVID-19 recovery (following negative PCR) 4-week follow-up of the hospitalized patients.

Parameters Initial findings (admission day) Post-COVID-19 4-week follow-up
Patients (n) Male Female Patients Male Female
Chest X ray 62 55 7 3 (0.48%) 2 (3.6%) 1 (14.2%)
Decreased Hb 31 (50%) 28 (50.9%) 4 (57.1%) 26 (41.9%) 23 (41.8%) 3 (42.8%)
Increased ESR 43 (69.4%) 39 (70.9%) 4 (57.1%) 34 (54.8%) 30 (54.5%) 4 (57.1%)
Leukocytosis 8 (12.9%) 6 (10.9%) 2 (28.6%) 10 (16.1%) 9 (16.3%) 1 (14.2%)
Decreased RBC 4 (6.5%) 0 4 (57.1%) 3 (4.84%) 0 3 (42.8%)
Platelet 0 0 0 0 0 0
Neutrophil ↑11 (17.7%) ↑10 (18.2%) ↑1 (14.3%) ↑4 (33.8%) ↑4 (7.2%) 0
Lymphocyte 11 (17.7%) 10 (18.2%) 1 (14.3%) ↑9 (14.5%) ↑7 (12.7%) ↑2 (28.6%)
Monocyte ↑↓ 0 0 0 0 0 0
Esinophil ↑↓ 0 0 0 0 0 0
Basophil ↑↓ 0 0 0 0 0 0
Increased CRP 62 (100%) 55 (100%) 7 (100%) 11 (17.7%) 8 (14.5%) 3 (42.8%)
Increased SGPT 18 (29%) 16 (29%) 2 (28.6%) 3 (4.8%) 3 (5.4%) 0
Increased ferritin 28 (45.1%) 25 (45.5%) 3 (42.9%) 6 (9.7%) 5 (9.1%) 1 (14.2%)
Increased PT 14 (22.6%) 11 (20%) 3 (42.9%) 16 (25.8%) 13 (23.6%) 3 (42.8%)
Increased D-dimer 31 (50%) 29 (52.7%) 2 (28.6%) 4 (6.4%) 4 (7.3%) 0
Increased creatinine 2 (3.2%) 2 (3.6%) 0 0 0 0

The total number of patients (n = 62); Male: 55, Female: 7. Reference value: Hb (g/dl): Female: 12–16; Male: 14–18; ESR (mm in first hour): Female: 0–15; Male: 0–10; WBC/CC: 4,000–11,000; RBC (Million/CC): 4.0–6.2; Platelet/CC: 150,000–450,000; Neutrophil: 40%−75%; Lymphocyte: 20–45%; Monocyte: 2–10%; Eosinophil: 1–6%; Basophil: 0–1%; CRP (mg/dl): <3; SGPT (Units/L) Male: 16–63 Female: 14–59; Serum ferritin (ng/ml): Male: 13–370, Female: 9–253; PT (s): 0–13. COVID-19, coronavirus disease 2019; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; Hb, hemoglobin; PT, prothrombin time; RBC, red blood cell; SGPT, serum glutamic pyruvic transaminase; WBC, white blood cell. ↑increase value, ↓decrease value.